EDGAR Filing Documents for 0001521536-14-000026

Form 8-K - Current report:

SEC Accession No. 0001521536-14-000026

Filing Date

2014-01-08

Accepted

2014-01-08 16:02:01

Documents

Period of Report

2014-01-02

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		q1101396_8k-biozone.htm	8-K	33389
2	AGREEMENT AND PLAN OF MERGER	q1101396_ex2-1.htm	EX-2.1	482548
3	CERTIFICATE OF MERGER	q1101396_ex2-2.htm	EX-2.2	11268
4	CERTIFICATE OF DESIGNATION - SERIES B	q1101396_ex3-1.htm	EX-3.1	23459
5	GARY WILCOX EMPLOYMENT AGREEMENT	q1101396_ex10-1.htm	EX-10.1	141063
6	SAM LEE EMPLOYMENT AGREEMENT	q1101396_ex10-2.htm	EX-10.2	145259
	Complete submission text file	0001521536-14-000026.txt		838545

Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632

Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101

BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)